This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
See Cramer's multi-million dollar portfolio for FREE and get his new book Get Rich Carefully! Learn More

Pacira Pharmaceuticals Inc. (PCRX)

NASDAQ: Health Care

Get a 5-page Ratings Report on (PCRX) now
$66.910.86 | 1.30%
04/21/14 - 11:31 AM ET
  • Latest Dividend: N/A
  • Latest Dividend Yield: N/A
  • Dividend Ex-Date: N/A
  • Price Earnings Ratio: -38.8238
  • Price Earnings Comparisons:
    PCRX Sector Avg. S&P 500
    -38.82 0.00 29.08
  • Price Performance History
    (% change):
    3 Mo 1 Yr 3 Yr
    1.47% 123.90% 823.78%
  • GROWTH 12 Mo 3 Yr CAGR
    Revenue 118.90 4.87 0.79
    Net Income 0.00 1.35 0.00
    EPS 0.00 -0.96 0.00
  • Earnings for PCRX:
    EBITDA -43,124,000
    REVENUE 85,551,000
Average Earnings Estimates
Qtr (03/14) Qtr (06/14) FY (12/14) FY (12/15)
Average Estimate $-0.22 $-0.17 $-0.33 $2.27
Number of Analysts 2 2 5 5
High Estimate $-0.17 $-0.13 $0.05 $3.30
Low Estimate $-0.27 $-0.22 $-0.60 $1.58
Prior Year $-0.61 $-0.42 $-1.71 $-0.33
Growth Rate (Year over Year) 63.93% 58.33% 80.58% 782.53%
(PCRX) News

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
DOW 16,435.51 +26.97 0.16%
S&P 500 1,868.52 +3.67 0.20%
NASDAQ 4,105.3680 +9.8520 0.24%

Brokerage Partners

Top Rated Stocks Top Rated Funds Top Rated ETFs